Sign In
Buy HCSG
$23.30
+0.220 (+0.95%)
At Close: Jul 31, 2026
Humana's (HUM) Earnings Beat Estimates in Q1, Improve Y/Y
04:45pm, Wednesday, 29'th Apr 2020
Humana's (HUM) first-quarter results reflect better revenues and growth in Medicare Advantage business.
Clark Estates Inc. NY Acquires New Position in Merck & Co., Inc. (NYSE:MRK)
02:53pm, Wednesday, 29'th Apr 2020
Clark Estates Inc. NY acquired a new stake in shares of Merck & Co., Inc. (NYSE:MRK) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor
Oppenheimer Believes Humana (HUM) Won't Stop Here
12:16pm, Wednesday, 29'th Apr 2020
In a report released today, Michael Wiederhorn from Oppenheimer maintained a Buy rating on Humana (HUM), with a price target of $400.00. The company's
Oppenheimer Believes Humana (NYSE: HUM) Won’t Stop Here
12:16pm, Wednesday, 29'th Apr 2020
In a report released today, Michael Wiederhorn from Oppenheimer maintained a Buy rating on Humana (HUM – Research Report), with
Merck & Company (MRK) Receives a Buy from Barclays
12:15pm, Wednesday, 29'th Apr 2020
Barclays analyst Carter Gould maintained a Buy rating on Merck & Company (MRK) yesterday and set a price target of $90.00. The company's shares closed
Merck & Company (MRK) Receives a Buy from Barclays
12:15pm, Wednesday, 29'th Apr 2020
Barclays analyst Carter Gould maintained a Buy rating on Merck & Company (MRK – Research Report) yesterday and set a
Bridgeworth LLC Boosts Stake in Merck & Co., Inc. (NYSE:MRK)
11:02am, Wednesday, 29'th Apr 2020
Bridgeworth LLC increased its position in Merck & Co., Inc. (NYSE:MRK) by 5.3% during the first quarter, Holdings Channel.com reports. The institutional investor owned 2,689 shares of the company’s
Blue Fin Capital Inc. Has $2.22 Million Stake in Merck & Co., Inc. (NYSE:MRK)
11:02am, Wednesday, 29'th Apr 2020
Blue Fin Capital Inc. decreased its stake in Merck & Co., Inc. (NYSE:MRK) by 1.0% in the 1st quarter, Holdings Channel.com reports. The fund owned 28,843 shares of the company’s stock after selling
Merck & Company (MRK) Gets a Buy Rating from Leerink Partners
10:58am, Wednesday, 29'th Apr 2020
In a report released today, Daina Graybosch from Leerink Partners maintained a Buy rating on Merck & Company (MRK), with a price target of $95.00. The
Humana Reports First Quarter 2020 Financial Results Including Proactive Actions Taken During Pandemic
10:30am, Wednesday, 29'th Apr 2020
Humana Inc. (NYSE: HUM) moved quickly during the first quarter of 2020 to ease some of the burden associated with the outbreak of the novel coronavirus, COVID-19, including assisting its employees to
Certified Advisory Corp Reduces Position in Merck & Co., Inc. (NYSE:MRK)
09:54am, Wednesday, 29'th Apr 2020
Certified Advisory Corp decreased its stake in shares of Merck & Co., Inc. (NYSE:MRK) by 6.0% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor
Alecta Pensionsforsakring Omsesidigt Makes New $47.72 Million Investment in Merck & Co., Inc. (NYSE:MRK)
09:12am, Wednesday, 29'th Apr 2020
Alecta Pensionsforsakring Omsesidigt purchased a new position in Merck & Co., Inc. (NYSE:MRK) in the first quarter, according to the company in its most recent disclosure with the Securities & Exchang
American Research & Management Co. Trims Stock Position in Merck & Co., Inc. (NYSE:MRK)
08:26am, Wednesday, 29'th Apr 2020
American Research & Management Co. lessened its holdings in Merck & Co., Inc. (NYSE:MRK) by 1.4% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission.
UMB Financial (NASDAQ:UMBF) Upgraded to Hold by BidaskClub
06:30am, Wednesday, 29'th Apr 2020
UMB Financial (NASDAQ:UMBF) was upgraded by BidaskClub from a “sell” rating to a “hold” rating in a note issued to investors on Wednesday, BidAskClub reports. UMBF has been the topic of severa
Why We’re Not Keen On MedApp S.A.’s (WSE:MDA) 7.1% Return On Capital
06:22am, Wednesday, 29'th Apr 2020
Today we are going to look at MedApp S.A. (WSE:MDA) to see whether it might be an attractive investment prospect...
